Antifibrogenic Therapies in Chronic HCV Infection

Publisher： Bentham Science Publishers

E-ISSN： 1875-5852|1|2|227-240

ISSN： 1568-0053

Source： Current Drug Targets - Infectious Disorders, Vol.1, Iss.2, 2001-08, pp. : 227-240

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential role for statins in the treatment of chronic HCV infection

By Zhu Qianqian   Han Qunying   Liu Zhengwen  

Future Virology, Vol. 8, Iss. 8, 2013-08 ,pp. : 727-729

Future Medicine

Access to resources Recommend Favorite

Therapies for Hepatitis C Infection: Targeting the Non-Structural Proteins of HCV

By  

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 1, Iss. 2, 2002-04 ,pp. : 163-176

Bentham Science Publishers

Access to resources Recommend Favorite

Peginterferon-α-2b: highs and lows in chronic HCV infection

By  

Reactions Weekly, Vol. 1, Iss. 1075, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Antiviral therapy in compensated and decompensated cirrhotic patients with chronic HCV infection

By Iacobellis Angelo   Andriulli Angelo  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 12, 2009-08 ,pp. : 1929-1938

Informa Healthcare

Access to resources Recommend Favorite

CD8+ T-cell differentiation in chronic HCV infection

By Bengsch Bertram   Thimme Robert  

Future Virology, Vol. 6, Iss. 2, 2011-02 ,pp. : 249-258

Future Medicine

Access to resources Recommend Favorite